Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 30, 2007. The document serves as a report regarding special resolutions passed at the Company's Annual General Meeting (AGM) held on May 23, 2007.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding corporate governance resolutions rather than a financial performance report.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this text. The filing focuses on the submission of AGM resolutions to the UK Listing Authority.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It confirms that copies of resolutions passed under special business at the AGM have been submitted to the UK Listing Authority and are available for inspection at the Financial Services Authority in London.
Investor Verification Checklist
- Verify the specific content of the special resolutions passed at the May 23, 2007 AGM via the UK Listing Authority's Document Viewing Facility.
- Confirm the availability of the full AGM minutes or separate financial reports for the period ending May 30, 2007, as this filing does not contain financial data.
- Check for subsequent filings (e.g., Form 20-F) for detailed financial performance metrics for the fiscal year.